Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

March 1, 2026

Conditions
Lung CarcinomaLung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the LungStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8
Interventions
PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PET

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Radiology, Treatment Planning

Undergo radiation planning with AI-directed analysis for dose recommendation

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

PROCEDURE

X-Ray Imaging

Undergo x-ray imaging

Trial Locations (1)

60611

RECRUITING

Northwestern University, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT05802186 - Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study | Biotech Hunter | Biotech Hunter